Request Trial
panel-8-gene-editing-and-advanced-therapies
21 May 2026VideosAmericasDavid Longmuir, Philip Ormonde Fitzpatrick | Danielle Burns, Philip Ormonde Fitzpatrick | Scott Douglas, Editas | Nicole Mastrangelo, The Broad Institute of MIT and Harvard

WATCH: Gene editing and advanced therapies—patent strategies for the next generation of precision medicine

The rapid evolution of CRISPR and base editing brings transformative medical potential alongside deeply complex IP and licensing hurdles. This session explores how companies can balance innovation with risk mitigation in a crowded and highly contested precision medicine landscape.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
Court upholds $83m sequencing verdict and sets royalty rate
17 June 2026   A cancer diagnostics company has lost its bid to overturn a jury verdict in a major patent dispute that has also spawned parallel proceedings before the Federal Circuit and PTAB.
Americas
Amgen and subsidiary dealt $20m blow over rodent antibody tech
15 June 2026   Unanimous jury finds willful infringement, with the possibility of a trebled award and a much larger feud still to come.
Americas
Moderna: BioNTech is claiming work ‘it never did’
12 June 2026   In a strong response to BioNTech, Moderna argues its next-gen vaccine is built on a fundamentally different design from the German biotech’s—setting up a scrap over whether a key patent should have been granted.


Editor's picks

Exelixis locks down cancer drug exclusivity until 2030 with Fed Circ win
Biotech
Exelixis locks down cancer drug exclusivity until 2030 with Fed Circ win
1 September 2026

Editor's picks

Biotech
Exelixis locks down cancer drug exclusivity until 2030 with Fed Circ win
1 September 2026
MedTech
Abbott fends off Chinese rival’s patent challenge at UPC
18 August 2026
Regulation & Industry
Where Big Pharma is betting big in the M&A boom
29 July 2026
Regulation & Industry
Buying the brains: Why is Big Pharma shopping for innovation?
27 July 2026
Regulation & Industry
Why is 2026 already a record year for M&A activity?
17 July 2026
Biotech
Sanofi launches mRNA vaccine lawsuits at Moderna and Pfizer
15 July 2026

More features

J&J names two-decade veteran as chief IP counsel
J&J unit win shuts door on Sandoz generic launch
Italy’s Biofer falls short in Fed Circ appeal over key claim wording
California votes for law to restrict use of genAI by lawyers
Sun Pharma import ban back in force after Squires intervention
10x Genomics wins latest round in Parse patent dispute
White & Case life sciences co-leader moves firms
‘Busiest’ US district patent judge swaps bench for private practice